Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,466 | -20,672 | -13,745 | -8,063 | -8,141 |
| Depreciation Amortization | 2,569 | 1,972 | 1,166 | 339 | 370 |
| Other Working Capital | 647 | -580 | -890 | -929 | -2,317 |
| Other Operating Activity | 2,005 | 1,639 | 867 | 678 | 1,265 |
| Operating Cash Flow | $-22,245 | $-17,641 | $-12,602 | $-7,975 | $-8,823 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,836 | -71,294 | -76,234 | -65,090 | -7,257 |
| PPE Investments | -60 | -60 | -60 | N/A | -20 |
| Investing Cash Flow | $-54,896 | $-71,354 | $-76,294 | $-65,090 | $-7,277 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,524 | 85,503 | 85,503 | 85,481 | 18,728 |
| Other Financing Activity | -248 | -248 | -184 | -184 | -148 |
| Financing Cash Flow | $85,276 | $85,255 | $85,319 | $85,297 | $18,580 |
| Beginning Cash Position | 16,512 | 16,512 | 16,512 | 16,512 | 14,032 |
| End Cash Position | 24,647 | 12,772 | 12,935 | 28,744 | 16,512 |
| Net Cash Flow | $8,135 | $-3,740 | $-3,577 | $12,232 | $2,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,245 | -17,641 | -12,602 | -7,975 | -8,823 |
| Capital Expenditure | -60 | -60 | -60 | N/A | -20 |
| Free Cash Flow | -22,305 | -17,701 | -12,662 | -7,975 | -8,843 |